146 related articles for article (PubMed ID: 7857294)
1. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
2. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells.
Cailleteau C; Liagre B; Battu S; Jayat-Vignoles C; Beneytout JL
Anal Biochem; 2008 Sep; 380(1):26-34. PubMed ID: 18549804
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte cell sorting from diosgenin-differentiated human erythroleukemia cells by sedimentation field-flow fractionation.
Léger DY; Battu S; Liagre B; Beneytout JL; Cardot PJ
Anal Biochem; 2006 Aug; 355(1):19-28. PubMed ID: 16806034
[TBL] [Abstract][Full Text] [Related]
4. A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation.
Cailleteau C; Liagre B; Beneytout JL
J Cell Biochem; 2009 Jul; 107(4):785-96. PubMed ID: 19415684
[TBL] [Abstract][Full Text] [Related]
5. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
6. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(4B):3229-35. PubMed ID: 10652616
[TBL] [Abstract][Full Text] [Related]
7. Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells.
Leger DY; Liagre B; Beneytout JL
Int J Oncol; 2006 Jan; 28(1):201-7. PubMed ID: 16327997
[TBL] [Abstract][Full Text] [Related]
8. Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells.
Ghezali L; Liagre B; Limami Y; Beneytout JL; Leger DY
PLoS One; 2014; 9(4):e95016. PubMed ID: 24740159
[TBL] [Abstract][Full Text] [Related]
9. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
10. Changes in lipoxygenase activities in human erythroleukemia (HEL) cells during diosgenin-induced differentiation.
Nappez C; Liagre B; Beneytout JL
Cancer Lett; 1995 Sep; 96(1):133-40. PubMed ID: 7553601
[TBL] [Abstract][Full Text] [Related]
11. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S
Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152
[TBL] [Abstract][Full Text] [Related]
12. IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line.
Majumdar A; Kerby S; Stenberg PE; Mullikin B; Beckstead JH; Cooney DA; Seidman MM
J Cell Physiol; 1994 Jul; 160(1):29-39. PubMed ID: 8021297
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin dose-dependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring.
Léger DY; Liagre B; Cardot PJ; Beneytout JL; Battu S
Anal Biochem; 2004 Dec; 335(2):267-78. PubMed ID: 15556566
[TBL] [Abstract][Full Text] [Related]
14. Investigating the relationship between cell cycle stage and diosgenin-induced megakaryocytic differentiation of HEL cells using sedimentation field-flow fractionation.
Cailleteau C; Micallef L; Lepage C; Cardot PJ; Beneytout JL; Liagre B; Battu S
Anal Bioanal Chem; 2010 Oct; 398(3):1273-83. PubMed ID: 20714892
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
16. Sedimentation field flow fractionation to study human erythroleukemia cell megakaryocytic differentiation after short period diosgenin induction.
Léger DY; Battu S; Liagre B; Cardot PJ; Beneytout JL
J Chromatogr A; 2007 Jul; 1157(1-2):309-20. PubMed ID: 17499257
[TBL] [Abstract][Full Text] [Related]
17. Regulation of megakaryocyte phenotype in human erythroleukemia cells.
Long MW; Heffner CH; Williams JL; Peters C; Prochownik EV
J Clin Invest; 1990 Apr; 85(4):1072-84. PubMed ID: 2318965
[TBL] [Abstract][Full Text] [Related]
18. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
[TBL] [Abstract][Full Text] [Related]
19. Expression and activation of protein kinase C isoforms in a human megakaryocytic cell line.
Ballen KK; Ritchie AJ; Murphy C; Handin RI; Ewenstein BM
Exp Hematol; 1996 Nov; 24(13):1501-8. PubMed ID: 8950233
[TBL] [Abstract][Full Text] [Related]
20. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
Cellai C; Laurenzana A; Vannucchi AM; Della Malva N; Bianchi L; Paoletti F
FASEB J; 2002 May; 16(7):733-5. PubMed ID: 11923217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
